Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017, Article ID 2590676, 9 pages
https://doi.org/10.1155/2017/2590676
Research Article

Apigenin Attenuates Adriamycin-Induced Cardiomyocyte Apoptosis via the PI3K/AKT/mTOR Pathway

1Department of Pharmacology, Hubei University of Science and Technology, Xianning 437100, China
2Department of Cardiology, Xianning Central Hospital, Xianning 437100, China
3Department of Surgery, Hubei University of Science and Technology, Xianning 437100, China

Correspondence should be addressed to Qing Min; moc.361@8260nimiab and Jiliang Wu; moc.361@ljwyx

Received 9 January 2017; Revised 10 March 2017; Accepted 19 April 2017; Published 8 June 2017

Academic Editor: Omer Kucuk

Copyright © 2017 Wei Yu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Bonadonna, F. Fossati-Bellani, S. Monfardini, and M. de Lena, “Clinical evaluation of adriamycin, a new antitumour antibiotic,” British Medical Journal, vol. 3, no. 5669, pp. 503–506, 1969. View at Publisher · View at Google Scholar · View at Scopus
  2. A. H. Ragab, W. W. Sutow, D. M. Komp, K. A. Starling, G. M. Lyon, and S. George, “Adriamycin in the treatment of childhood acute leukemia. A Southwest Oncology Group study,” Cancer, vol. 36, no. 4, pp. 1223–1226, 1975. View at Google Scholar
  3. G. Bacci, P. Picci, S. Ferrari et al., “Influence of adriamycin dose in the outcome of patients with osteosarcoma treated with multidrug neoadjuvant chemotherapy: results of two sequential studies,” Journal of Chemotherapy, vol. 5, no. 4, pp. 237–246, 1993. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Xin, S. Zhang, L. Gu et al., “Electrocardiographic and biochemical evidence for the cardioprotective effect of antioxidants in acute doxorubicin-induced cardiotoxicity in the beagle dogs,” Biological and Pharmaceutical Bulletin, vol. 34, no. 10, pp. 1523–1526, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Akolkar, N. Bhullar, H. Bews et al., “The role of renin angiotensin system antagonists in the prevention of doxorubicin and trastuzumab induced cardiotoxicity,” Cardiovascular Ultrasound, vol. 13, no. 1, article 18, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Wu, W. Guo, S.-Z. Lin et al., “Gp130-mediated STAT3 activation by S-propargyl-cysteine, an endogenous hydrogen sulfide initiator, prevents doxorubicin-induced cardiotoxicity,” Cell Death Discovery, vol. 7, article e2339, no. 8, 2016. View at Google Scholar
  7. L. Lu, W. Wu, J. Yan, X. Li, H. Yu, and X. Yu, “Adriamycin-induced autophagic cardiomyocyte death plays a pathogenic role in a rat model of heart failure,” International Journal of Cardiology, vol. 134, no. 1, pp. 82–90, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Liu, H. Wang, D. Xiang, and W. Guo, “Pharmaceutical measures to prevent doxorubicin-induced cardiotoxicity,” Mini-Reviews in Medicinal Chemistry, 2016. View at Google Scholar
  9. M. Venigalla, E. Gyengesi, and G. Münch, “Curcumin and apigenin—novel and promising therapeutics against chronic neuroinflammation in Alzheimer's disease,” Neural Regeneration Research, vol. 10, no. 8, pp. 1181–1185, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Zhang, X. Liu, C. Sun et al., “Apigenin attenuates experimental autoimmune myocarditis by modulating Th1/Th2 cytokine balance in mice,” Inflammation, vol. 39, no. 2, pp. 678–686, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Zhang, T. Yan, J. Du, S. Wang, and H. Yang, “Apigenin attenuates heart injury in lipopolysaccharide-induced endotoxemic model by suppressing sphingosine kinase 1/sphingosine 1-phosphate signaling pathway,” Chemico-Biological Interactions, vol. 233, pp. 46–55, 2015. View at Publisher · View at Google Scholar
  12. J. Hu, Z. Li, L. T. Xu et al., “Protective effect of apigenin on ischemia/reperfusion injury of the isolated rat heart,” Cardiovascular Toxicology, vol. 15, no. 3, pp. 241–249, 2015. View at Google Scholar
  13. C. Chen, H. He, Y. Luo, M. Zhou, D. Yin, and M. He, “Involvement of Bcl-2 signal pathway in the protective effects of apigenin on anoxia/reoxygenation-induced myocardium injury,” Journal of Cardiovascular Pharmacology, vol. 67, no. 2, pp. 152–163, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Psotová, Š. Chlopčíkova, P. Miketová, J. Hrbác, and V. Šimánek, “Chemoprotective effect of plant phenolics against anthracycline-induced toxicity on rat cardiomyocytes. Part III. Apigenin, baicalelin, kaempherol, luteolin and quercetin,” Phytotherapy Research, vol. 18, no. 7, pp. 516–521, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Alsuhailbani, A. Menon, and C. Nair, “Protective effect of ayurvedic formulations against doxorubicin-induced cardiotoxicity: preliminary studies on Brahma Rasayana and Chyavanaprash,” Journal of Cancer Research and Therapeutics, vol. 12, no. 2, pp. 561–564, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Kobayashi, F. Usui, T. Karasawa et al., “NLRP3 Deficiency Reduces Macrophage Interleukin-10 Production and Enhances the Susceptibility to Doxorubicin-induced Cardiotoxicity,” Scientific Reports, vol. 6, Article 26489, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. V. G. Desai, E. H. Herman, C. L. Moland et al., “Development of doxorubicin-induced chronic cardiotoxicity in the B6C3F1 mouse model,” Toxicology and Applied Pharmacology, vol. 266, no. 1, pp. 109–121, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Pacher, L. Liaudet, P. Bai et al., “Activation of poly(ADP-ribose) polymerase contributes to development of doxorubicin-induced heart failure,” Journal of Pharmacology and Experimental Therapeutics, vol. 300, no. 3, pp. 862–867, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. S. N. Goyal, U. B. Mahajan, G. Chandrayan et al., “Protective effect of oleanolic acid on oxidative injury and cellular abnormalities in doxorubicin induced cardiac toxicity in rats,” American Journal of Translational Research, vol. 8, no. 1, pp. 60–69, 2016. View at Google Scholar
  20. B. S. Lee, J. Oh, S. K. Kang et al., “Insulin protects cardiac myocytes from doxorubicin toxicity by Sp1-mediated transactivation of survivin,” PLoS ONE, vol. 10, no. 8, Article ID e0135438, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. C.-C. Lin, Y.-J. Chuang, C.-C. Yu et al., “Apigenin induces apoptosis through mitochondrial dysfunction in U-2 OS human osteosarcoma cells and inhibits osteosarcoma xenograft tumor growth in vivo,” Journal of Agricultural and Food Chemistry, vol. 60, no. 45, pp. 11395–11402, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Budhraja, N. Gao, Z. Zhang et al., “Apigenin induces apoptosis in human leukemia cells and exhibits anti-leukemic activity in vivo,” Molecular Cancer Therapeutics, vol. 11, no. 1, pp. 132–142, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Angsutararux, S. Luanpitpong, and S. Issaragrisil, “Chemotherapy-induced cardiotoxicity: overview of the roles of oxidative stress,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 795602, 13 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. X. Lv, X. Yu, Y. Wang et al., “Berberine inhibits doxorubicin-triggered cardiomyocyte apoptosis via attenuating mitochondrial dysfunction and increasing Bcl-2 expression,” PLoS ONE, vol. 7, no. 10, Article ID e47351, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. X. Xu, K. Chen, S. Kobayashi, D. Timm, and Q. Liang, “Resveratrol attenuates doxorubicin-induced cardiomyocyte death via inhibition of p70 S6 kinase 1-mediated autophagy,” The Journal of Pharmacology and Experimental Therapeutics, vol. 341, no. 1, pp. 183–195, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Kobayashi, P. Volden, D. Timm, K. Mao, X. Xu, and Q. Liang, “Transcription factor GATA4 inhibits doxorubicin-induced autophagy and cardiomyocyte death,” The Journal of Biological Chemistry, vol. 285, no. 1, pp. 793–804, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Gu, W. Hu, and D.-D. Zhang, “Resveratrol, a polyphenol phytoalexin, protects against doxorubicin-induced cardiotoxicity,” Journal of Cellular and Molecular Medicine, vol. 19, no. 10, pp. 2324–2328, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Pattingre, A. Tassa, X. Qu et al., “Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy,” Cell, vol. 122, no. 6, pp. 927–939, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Sung, H. Y. Chung, and N. D. Kim, “Role of apigenin in cancer prevention via the induction of apoptosis and autophagy,” Journal of Cancer Prevention, vol. 21, no. 4, pp. 216–226, 2016. View at Google Scholar
  30. N. Mohan, N. L. Banik, and S. K. Ray, “Combination of N-(4-hydroxyphenyl) retinamide and apigenin suppressed starvation-induced autophagy and promoted apoptosis in malignant neuroblastoma cells,” Neuroscience Letters, vol. 502, no. 1, pp. 24–29, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. Z. G. Wang, Y. Wang, Y. Huang et al., “bFGF regulates autophagy and ubiquitinated protein accumulation induced by myocardial ischemia/reperfusion via the activation of the PI3K/Akt/mTOR pathway,” Scientific Reports, vol. 5, article 9287, 2015. View at Publisher · View at Google Scholar
  32. X. Wang, X.-L. Wang, H.-L. Chen et al., “Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK,” Biochemical Pharmacology, vol. 88, no. 3, pp. 334–350, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Pisonero-Vaquero, M. V. García-Mediavilla, F. Jorquera et al., “Modulation of PI3K-LXRα-dependent lipogenesis mediated by oxidative/nitrosative stress contributes to inhibition of HCV replication by quercetin,” Laboratory Investigation, vol. 94, no. 3, pp. 262–274, 2014. View at Publisher · View at Google Scholar · View at Scopus